跳至主要内容
临床试验/ACTRN12623001178639
ACTRN12623001178639招募中Unknown

A prospective pilot study of biofeedback training with Contrain” in patients with major LARS and faecal incontinence symptoms after anterior resection for rectal cancer

niversity of Otago0 个研究点目标入组 20 人开始时间: 2023年11月14日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Previous rectal cancer surgery
  • 2. Full continuity of the gastrointestinal tract (If a stoma was formed it has subsequently been closed at least a year prior to enrolment in this study)
  • 3. Major LARS (score > 30)
  • 4. Previous treatment has been given for LARS, including medications such as loperamide, dietary advice and treatment for bile acid malabsorption (BAM).
  • 5. Aged 18-80
  • 6. Able to give informed consent
  • 7. Participant is available to commit to up to 36 weeks of biofeedback training.
  • 8. Participant is sufficiently motivated to commit to two training sessions a day for 6-9 months.

排除标准

  • Cognitive disorders impeding pelvic floor rehabilitation.

研究者

相似试验